Unilever’s prestige beauty business, bulked up by acquisitions over the past five years, achieved 21% underlying sales growth in the FY 2021 first quarter. The firm has formed a new business unit, Elida Beauty, to house a number of smaller, non-core beauty and personal-care brands accounting for around €600m in revenues following talk of possible divestitures.
Unilever plc has separated a number of smaller beauty and personal-care brands into their own business unit, Elida Beauty, while training its focus on higher-growth prestige beauty and functional nutrition.
The firm has been talking about potentially making divestitures from its Beauty & Personal Care division to tidy its portfolio...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
